Nanoemulsion Market

Nanoemulsion Market (Drug Class - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials, and Vasodilators; Route of Administration - Topical, Oral, Parenteral, and Nasal; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, and E-commerce) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

  • Rep Id : TMRGL15473
  • Published On : Sep 2017
  • No. of Pages : 191
  • Category : Pharmaceutical

Section 1 Preface 
1.1 Report Scope and Market Segmentation 
1.2 Research Highlights

Section-2 Assumptions and Research Methodology 
2.1 Assumptions and Acronyms Used
2.2 Research Methodology

Section-3 Executive Summary
3.1 Global Nanoemulsion Market: Market Snapshot
3.2 Global Nanoemulsion Market: Opportunity Map

Section-4 Market Overview
4.1 Global Nanoemulsion Market: Product Overview
4.2 Global Nanoemulsion Market: Key Industry Developments

Section-5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
      5.1.2 Drivers
      5.1.3 Restraints
      5.1.4 Opportunity
5.2 Opportunity Analysis
5.3 Key Trends
5.4 Global Nanoemulsion Market Revenue Forecast
5.5 Porter’s Five Forces Analysis 
5.6 PEST Analysis
5.7 Value Chain Analysis
5.8 Global Nanoemulsion Market Outlook

Section-6 Global Nanoemulsion Market Analysis, by Drug Class
6.1 Key Findings
6.2 Introduction
6.3 Global Nanoemulsion Market Value Share Analysis, by Drug Class
6.4 Global Nanoemulsion Market Forecast, by Drug Class
      6.4.1 Steroids
      6.4.2 Aesthetics
      6.4.3 NSAIDs
      6.4.4 Immunosuppressant
      6.4.5 Antiretroviral
      6.4.6 Antimicrobials
      6.4.7 Vasodilators
      6.4.8 Others 
6.5 Global Nanoemulsion Market Attractiveness Analysis, By Drug Class

Section-7 Global Nanoemulsion Market Analysis, by Route of Administration
7.1 Key Findings
7.2 Introduction
7.3 Global Nanoemulsion Market Value Share Analysis, by Route of Administration
7.4 Market Value (US$ Mn) Forecast By Route of Administration 
      7.4.1 Topical
      7.4.2 Oral
      7.4.3 Parenteral 
      7.4.4 Nasal
      7.4.5 Others
7.5 Global Nanoemulsion Market Attractiveness Analysis, By Route of Administration

Section-8 Global Nanoemulsion Market Analysis, by Distribution Channel
8.1 Key Findings
8.2 Introduction
8.3 Global Nanoemulsion Market Value Share Analysis, by Distribution Channel 
8.4 Market Value (US$ Mn) Forecast By Distribution Channel 
      8.4.1 Hospital Pharmacies
      8.4.2 Retail Pharmacies      
      8.4.3 E-Commerce
8.5 Global Nanoemulsion Market Attractiveness Analysis, By Distribution Channel 

Section-9 Global Nanoemulsion Market Analysis, by Region
9.1 Geographical Scenario
9.2 Introduction
9.3 Nanoemulsion Market Value Share Analysis, by Region, 2017 and 2025 
9.4 Nanoemulsion Market Forecast, by Region
      9.4.1 North America
      9.4.2 Europe
      9.4.3 Asia Pacific
      9.4.4 Latin America
      9.4.1 Middle East & Africa
9.5. Nanoemulsion Market Attractiveness Analysis, By Region, 2017 and 2025

Section-10 North America Nanoemulsion Market Analysis and Forecast 
10.1 Key Findings
10.2 Market Value (US$ Mn) Forecast, By Country 
      10.2.1 U.S.
      10.2.2 Canada
10.3 Market Value (US$ Mn) Forecast By Drug Class 
10.4 Market Value (US$ Mn) Forecast By Route of Administration
10.5 Market Value (US$ Mn) Forecast By Distribution Channel
10.6 Market Attractiveness Analysis
      10.6.1 By Country 
      10.6.2 By Drug Class
      10.6.3 By Route of Administration
      10.6.4 By Distribution Channel

Section-11 Europe Nanoemulsion Market Analysis and Forecast
11.1 Key Findings
11.2 Market Value (US$ Mn) Forecast, By Country 
      11.2.1 Germany
      11.2.2 France
      11.2.3 U.K.
      11.2.4 Spain
      11.2.5 Italy
      11.2.6 Rest of Europe
11.3 Market Value (US$ Mn) Forecast By Drug Class
11.4 Market Value (US$ Mn) Forecast By Route of Administration
11.5 Market Value (US$ Mn) Forecast By Distribution Channel
11.6 Market Attractiveness Analysis 
      11.4.1 By Country
      11.4.2 By Drug Class
      11.4.3 By Route of Administration
      11.4.4 By Distribution Channel

Sectin-12 Asia Pacific Nanoemulsion Market Analysis and Forecast
12.1 Key Findings
12.2 Market Value (US$ Mn) Forecast, By Country 
      12.2.1 China
      12.2.2 Japan
      12.2.3 India
      12.2.4 Australia
      12.2.5 Rest of APAC
12.3 Market Value (US$ Mn) Forecast By Drug Class
12.4 Market Value (US$ Mn) Forecast By Route of Administration
12.5 Market Value (US$ Mn) Forecast By Distribution Channel
12.6 Market Attractiveness Analysis 
      12.4.1 By Country
      12.4.2 By Drug Class
      12.4.3 By Route of Administration
      12.4.4 By Distribution Channel

Section-13 Latin America Nanoemulsion Market Analysis and Forecast
13.1 Key Findings
13.2 Market Value (US$ Mn) Forecast, By Country 
      13.2.1 Brazil
      13.2.2 Mexico
      13.2.3 Rest of LATAM      
      13.2.5 Rest of APAC
13.3 Market Value (US$ Mn) Forecast By Drug Class
13.4 Market Value (US$ Mn) Forecast By Route of Administration
13.5 Market Value (US$ Mn) Forecast By Distribution Channel
13.6 Market Attractiveness Analysis 
      13.4.1 By Country
      13.4.2 By Drug Class
      13.4.3 By Route of Administration
      13.4.4 By Distribution Channel

Section-14 Latin America Nanoemulsion Market Analysis and Forecast
14.1 Key Findings
14.2 Market Value (US$ Mn) Forecast, By Country 
      14.2.1 Saudi Arabia
      14.2.2 South Africa
      14.2.3 Rest of MEA
14.3 Market Value (US$ Mn) Forecast By Drug Class
14.4 Market Value (US$ Mn) Forecast By Route of Administration
14.5 Market Value (US$ Mn) Forecast By Distribution Channel
14.6 Market Attractiveness Analysis 
      14.4.1 By Country
      14.4.2 By Drug Class
      14.4.3 By Route of Administration
      14.4.4 By Distribution Channel

Section-15 Competition Landscape
15.1 Global Nanoemulsion Market Share Analysis, by Company (2016)
15.2 Competition Matrix
15.3 Company profiles
      15.3.1 AbbVie Inc.
               15.3.1.1 Company Details
               15.3.1.2 Business Overview
               15.3.1.3 Financial Overview
               15.3.1.4 Strategic Overview
               15.3.1.5 SWOT Analysis
      15.3.2 Allergan plc.
               15.3.2.1 Company Details
               15.3.2.2 Business Overview
               15.3.2.3 Financial Overview
               15.3.2.4 Strategic Overview
               15.3.2.5 SWOT Analysis
      15.3.3 AstraZeneca
               15.3.3.1 Company Details
               15.3.3.2 Business Overview
               15.3.3.3 Financial Overview
               15.3.3.4 Strategic Overview
               15.3.3.5 SWOT Analysis
      15.3.4 Fresenius Kabi AG
               15.3.4.1 Company Details
               15.3.4.2 Business Overview
               15.3.4.3 Financial Overview
               15.3.4.4 Strategic Overview
               15.3.4.5 SWOT Analysis
      15.3.5 Kaken Pharmaceutical Co., Ltd.
               15.3.5.1 Company Details
               15.3.5.2 Business Overview
               15.3.5.3 Financial Overview
               15.3.5.4 Strategic Overview
               15.3.5.5 SWOT Analysis
      15.3.6 Mitsubishi Tanabe Pharma Corporation
               15.3.6.1 Company Details
               15.3.6.2 Business Overview
               15.3.6.3 Financial Overview
               15.3.6.4 Strategic Overview
               15.3.6.5 SWOT Analysis
      15.3.7 NanoBio Corporation
               15.3.7.1 Company Details
               15.3.7.2 Business Overview
               15.3.7.3 Financial Overview
               15.3.7.4 Strategic Overview
               15.3.7.5 SWOT Analysis
      15.3.8 Novartis AG
               15.3.8.1 Company Details
               15.3.8.2 Business Overview
               15.3.8.3 Financial Overview
               15.3.8.4 Strategic Overview
               15.3.8.5 SWOT Analysis
      15.3.9 GlaxoSmithKline plc.
               15.3.9.1 Company Details
               15.3.9.2 Business Overview
               15.3.9.3 Financial Overview
               15.3.9.4 Strategic Overview
               15.3.9.5 SWOT Analysis
      15.3.10 Sanofi
               15.3.10.1 Company Details
               15.3.10.2 Business Overview
               15.3.10.3 Financial Overview
               15.3.10.4 Strategic Overview
               15.3.10.5 SWOT Analysis
      15.3.11 B. Braun Melsungen AG
               15.3.11.1 Company Details
               15.3.11.2 Business Overview
               15.3.11.3 Financial Overview
               15.3.11.4 Strategic Overview
               15.3.11.5 SWOT Analysis

List of Tables

Table 01: List of Commercially Available Nanoemulsion
Table 02: Global Nanoemulsion Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 03: Global Nanoemulsion Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
Table 04: Global Nanoemulsion Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 05: Global Nanoemulsion Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 06: North America Nanoemulsion Market Size (US$ Mn) and Forecast, by Country, 2015–2025
Table 07: North America Nanoemulsion Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 08: North America Nanoemulsion Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
Table 09: North America Nanoemulsion Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 10: Europe Nanoemulsion Market Size (US$ Mn) and Forecast, by Country, 2015–2025
Table 11: Europe Nanoemulsion Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 12: Europe Nanoemulsion Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
Table 13: Europe Nanoemulsion Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 14: Asia Pacific Nanoemulsion Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 15: Asia Pacific Nanoemulsion Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 16: Asia Pacific Nanoemulsion Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
Table 17: Asia Pacific Nanoemulsion Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 18: Latin America Nanoemulsion Market Size (US$ Mn) and Forecast, by Country, 2015–2025
Table 19: Latin America Nanoemulsion Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 20: Latin America Nanoemulsion Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
Table 21: Latin America Nanoemulsion Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 22: Middle East & Africa Nanoemulsion Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 23: Middle East & Africa Nanoemulsion Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 24: Middle East & Africa Nanoemulsion Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
Table 25: Middle East & Africa Nanoemulsion Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025

List of Figures
 
Figure 01: Global Nanoemulsion Market Size (US$ Mn) Forecast, 2014–2024
Figure 02: Market Revenue Share, by Drug Class (2016)
Figure 03: Market Volume Share, by Distribution Channel (2016)
Figure 04: Market Revenue Share, by Route of Administration (2016)
Figure 05: Market Volume Share, by Region (2016)
Figure 06: Global Nanoemulsion Market Value Share Analysis, Drug Class, 2017 and 2025
Figure 07: Global Nanoemulsion Market Size (US$ Mn) and Y-o-Y Growth, by Steroids, 2015-2025
Figure 08: Global Nanoemulsion Market Size (US$ Mn) and Y-o-Y Growth, by Anesthetics, 2015-2025
Figure 09: Global Nanoemulsion Market Size (US$ Mn) and Y-o-Y Growth, by NSAIDs, 2015-2025
Figure 10: Global Nanoemulsion Market Size (US$ Mn) and Y-o-Y Growth, by Immunosuppressant, 2015-2025
Figure 11: Global Nanoemulsion Market Size (US$ Mn) and Y-o-Y Growth, by Antiretroviral, 2015-2025
Figure 12: Global Nanoemulsion Market Size (US$ Mn) and Y-o-Y Growth, by Antimicrobials, 2015-2025
Figure 13: Global Nanoemulsion Market Size (US$ Mn) and Y-o-Y Growth, by Vasodilators, 2015-2025
Figure 14: Global Nanoemulsion Market Size (US$ Mn) and Y-o-Y Growth, by Others, 2015-2025
Figure 15: Global Nanoemulsion Market Attractiveness Analysis, by Drug Class, 2017–2025
Figure 16: Global Nanoemulsion Market Value Share Analysis, by Route of Administration, 2017 and 2025
Figure 17: Global Nanoemulsion Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Topical, 2015–2025
Figure 18: Global Nanoemulsion Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Oral, 2015–2025
Figure 19: Global Nanoemulsion Market Value (US$ Mn) and
Figure 20: Global Nanoemulsion Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Nasal, 2015–2025
Figure 21: Global Nanoemulsion Market Value (US$ Mn) and
Figure 22: Global Nanoemulsion Market Attractiveness Analysis,
Figure 23: Global Nanoemulsion Market Value Share Analysis, by Distribution Channel, 2017 and 2025
Figure 24: Global Nanoemulsion Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2015–2025
Figure 25: Global Nanoemulsion Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2015– 2025
Figure 26: Global Nanoemulsion Market Revenue (US$ Mn) and Y-o-Y Growth (%), by E- Commerce, 2015–2025
Figure 27: Global Nanoemulsion Market Attractiveness Analysis,
Figure 28: Global Nanoemulsion Market Value Share Analysis, by Region, 2017 and 2025
Figure 29: Global Nanoemulsion Market Attractiveness Analysis, 
Figure 30: North America Nanoemulsion Market Size (US$ Mn) Forecast, 2015–2025
Figure 31: North America Nanoemulsion Market Size, Y-o-Y Growth Projection, 2017–2025
Figure 32: North America Nanoemulsion Market Attractiveness Analysis, by Country
Figure 33: North America Nanoemulsion Market Value Share Analysis, by Country, 2017 and 2025
Figure 34: North America Nanoemulsion Market Value Share Analysis, by Drug Class, 2017 and 2025
Figure 35: North America Nanoemulsion Market Attractiveness Analysis, by Drug Class, 2017–2025
Figure 36: North America Nanoemulsion Market Value Share Analysis, by Route of Administration, 2017 and 2025
Figure 37: North America Nanoemulsion Market Attractiveness Analysis, by Route of Administration, 2017-2025
Figure 38: North America Nanoemulsion Market Value Share Analysis, by Distribution Channel, 2017 and 2025
Figure 39: North America Nanoemulsion Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 40: Europe Nanoemulsion Market Size (US$ Mn) Forecast, 2015–2025
Figure 41: Europe Nanoemulsion Market Size, Y-o-Y Growth Projection, 2017–2025
Figure 42: Europe Nanoemulsion Market Attractiveness Analysis, by Country
Figure 43: Europe Nanoemulsion Market Value Share Analysis, by Country, 2017 and 2025
Figure 44: Europe Nanoemulsion Market Value Share Analysis, by Drug Class, 2017 and 2025
Figure 45: Europe Nanoemulsion Market Attractiveness Analysis, by Drug Class, 2017–2025
Figure 46: Europe Nanoemulsion Market Value Share Analysis, by Route of Administration, 2017 and 2025
Figure 47: Europe Nanoemulsion Market Attractiveness Analysis, by Route of Administration, 2017–2025
Figure 48: Europe Nanoemulsion Market Value Share Analysis, by Distribution Channel, 2017 and 2025
Figure 49: Europe Nanoemulsion Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 50: Asia Pacific Nanoemulsion Market Size (US$ Mn) Forecast, 2015–2025
Figure 51: Asia Pacific Nanoemulsion Market Size, Y-o-Y Growth Projection, 2016–2025
Figure 52: Asia Pacific Nanoemulsion Market Attractiveness Analysis, by Country, 2017-2025
Figure 53: Asia Pacific Nanoemulsion Market Value Share Analysis, by Country, 2017 and 2025
Figure 54: Asia Pacific Nanoemulsion Market Value Share Analysis, by Drug Class, 2017 and 2025
Figure 55: Asia Pacific Nanoemulsion Market Attractiveness Analysis, by Drug Class, 2017–2025
Figure 56: Asia Pacific Nanoemulsion Market Value Share Analysis, by Route of Administration, 2017 and 2025
Figure 57: Asia Pacific Nanoemulsion Market Attractiveness Analysis, by Route of Administration, 2017–2025
Figure 58: Asia Pacific Nanoemulsion Market Value Share Analysis, by Distribution Channel, 2017 and 2025
Figure 59: Asia Pacific Nanoemulsion Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 60: Latin America Nanoemulsion Market Size (US$ Mn) Forecast, 2015–2025
Figure 61: Latin America Nanoemulsion Market Size, Y-o-Y Growth Projection, 2017–2025
Figure 62: Latin America Nanoemulsion Market Attractiveness Analysis, by Country
Figure 63: Latin America Nanoemulsion Market Value Share Analysis, by Country, 2017 and 2025
Figure 64: Latin America Nanoemulsion Market Value Share Analysis, by Drug Class, 2017 and 2025
Figure 65: Latin America Nanoemulsion Market Attractiveness Analysis, by Drug Class, 2017–2025
Figure 66: Latin America Nanoemulsion Market Value Share Analysis, by Route of Administration, 2017 and 2025
Figure 67: Latin America Nanoemulsion Market Attractiveness Analysis, by Route of Administration, 2017–2025
Figure 68: Latin America Nanoemulsion Market Value Share Analysis, by Distribution Channel, 2017 and 2025
Figure 69: Latin America Nanoemulsion Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 70: Middle East & Africa Nanoemulsion Market Size (US$ Mn) Forecast, 2015–2025
Figure 71: Middle East & Africa Nanoemulsion Market Size, Y-o-Y Growth Projection, 2017–2025
Figure 72: Middle East & Africa Nanoemulsion Market Attractiveness Analysis, by Country, 2017-2025
Figure 73: Middle East & Africa Nanoemulsion Market Value Share Analysis, by Country, 2017 and 2025
Figure 74: Middle East & Africa Nanoemulsion Market Value Share Analysis, by Drug Class, 2017 and 2025
Figure 75: Middle East & Africa Nanoemulsion Market Attractiveness Analysis, by Drug Class, 2017–2025
Figure 76: Middle East & Africa Nanoemulsion Market Value Share Analysis, by Route of Administration, 2017 and 2025
Figure 77: Middle East & Africa Nanoemulsion Market Attractiveness Analysis, by Route of Administration, 2017–2025
Figure 78: Middle East & Africa Nanoemulsion Market Value Share Analysis, by Distribution Channel, 2017 and 2025
Figure 79: Middle East & Africa Nanoemulsion Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 80: Global Nanoemulsion Market Heat Map Analysis By Company (2016)

.